Copyright © 2001 by the European Society of Cardiology.
Hotline Editorial
Clinical, public health, and research implications of the Heart Outcomes Prevention Evaluation (HOPE) Study
Division of Cardiology and Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada
References
- N Engl J Med. 2000;342:145153
[Abstract/Free Full Text] - N Engl J Med. 2000;342:154160
[Abstract/Free Full Text] - Flather MD, Yusuf S, Kober L. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group. Lancet. 2000;355:15751581[CrossRef][Web of Science][Medline]
- Lonn E, Yusuf S, Jha P. Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection. Circulation. 1994;4:20562069
- Lonn EM, Dzavik V, Yusuf S. Results of the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE). Circulation. 1999;100:I185
- Sleight P, Yusuf S, Pogue J. Reduction of events by ramipril in high-risk subjects is largely unrelated to blood pressure decrease. Presented at the 49th Annual Scientific Session of the American Congress of Cardiology, March 1215, 2000. Anaheim (CA). J Am Coll Cardiol. 2000;35:284A
- Held PH, Yusuf S, Furberg CD. Calcium channel blockers in acute myocardial infarction and unstable angina: an overview. BMJ. 1989;299:11871192
[Abstract/Free Full Text] - N Engl J Med. 1994;330:10291035
[Abstract/Free Full Text] - Lancet. 1999;354:447455[CrossRef][Web of Science][Medline]
This article has been cited by other articles:
![]() |
S. Gulec, A. Ruchan Akar, and N. Akar MEF2A Sequence Variants in Turkish Population Clinical and Applied Thrombosis/Hemostasis, October 1, 2008; 14(4): 465 - 467. [Abstract] [PDF] |
||||
![]() |
M. W Clarke, N. C Ward, J. H. Wu, J. M Hodgson, I. B Puddey, and K. D Croft Supplementation with mixed tocopherols increases serum and blood cell {gamma}-tocopherol but does not alter biomarkers of platelet activation in subjects with type 2 diabetes Am. J. Clinical Nutrition, January 1, 2006; 83(1): 95 - 102. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

